Cancer
Globe faces cancer ‘tidal wave’
February 5, 2014Research and Development, Sales and Marketing Cancer, WHO, globe, world cancer report
The World Health Organisation has warned of a ‘tidal wave’ of cancer cases which it says will sweep across the …
Cancer Research UK turns to gamification with app
February 4, 2014Medical Communications, Sales and Marketing CRUK, Cancer, Gamification, genes in space
Cancer Research UK has launched a new citizen science game aimed at helping its scientists discover new cures for cancer. …
Pfizer breast cancer drug shows promise
February 4, 2014Research and Development, Sales and Marketing Cancer, Pfizer, breast, femara, letrozole, palbociclib
Pfizer’s experimental breast cancer drug palbociclib has successfully extended progression-free survival in a Phase II trial. The pill was administered …
Cancer Drugs Fund: assessing a difficult legacy
February 3, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, NHS, NICE, adams, mccafferty
England’s Cancer Drugs Fund (CDF) is very good at creating division: its lobbyists say that it increases access to new …
Pfizer lung cancer drug suffers late-stage setback
January 28, 2014Research and Development, Sales and Marketing Cancer, NSCLC, Pfizer, Roche, Tarceva, dacomitinib
An experimental cancer drug developed by Pfizer has failed in two separate Phase III clinical studies. Dacomitinib is a tyrosine …
Elderly denied cancer treatment on NHS
January 24, 2014Sales and Marketing Cancer, Macmillan, NCIN, NHS, elderly
A UK charity is warning the NHS not to write off older cancer patients as ‘too old’ for treatment. With …
GSK has Tafinlar ‘breakthrough’
January 15, 2014Sales and Marketing Cancer, FDA, GSK, NSCLC, Tafinlar
GlaxoSmithKline is on a roll, with its cancer drug Tafinlar given breakthrough therapy designation by the FDA in lung cancer …
UK cancer figures rise
January 15, 2014Research and Development, Sales and Marketing Cancer, England, NHS, research uk
More people are being diagnosed with cancer than ever before, according to figures from Cancer Research UK – as an …
UK cancer death rate could be halved by 2030
January 10, 2014Research and Development, Sales and Marketing Cancer, Taylor, UCL, wardle
British cancer deaths could drop 50% by 2030 if early diagnosis and improved treatment policies are put in place academics …
Cancer treatment Abraxane gets EU nod
January 9, 2014Sales and Marketing Abraxane, Cancer, Celgene, EU, pancreatic
Celgene’s cancer drug Abraxane has been approved by European regulators to treat patients with metastatic adenocarcinoma of the pancreas, or …
AstraZeneca strikes cancer vaccine pact
January 8, 2014Research and Development, Sales and Marketing AstraZeneca, Cancer, MedImmune, oncology
AstraZeneca’s biologics arm MedImmune has struck an oncology research deal with UK biotech company Immunocore. The deal, which could be …
AZ and Horizon in cancer tie-up
January 8, 2014Research and Development, Sales and Marketing AstraZeneca, Cancer, horizon, medimunne
AstraZeneca has signed a deal with British biotech firm Horizon Discovery to look at a number of genotypes to see …
US cancer research receives $540 million
January 7, 2014Research and Development, Sales and Marketing Cancer, US, licr, ludwig
Six facilities in the US have received a total of $540 million from the estate of an American businessman in …
Cancer patients lose out in NHS overspend
January 6, 2014Research and Development, Sales and Marketing Cancer, Macmillan, NHS England
Patients in the NHS may not be able to receive new treatments for cancer as it emerges that health chiefs …
Cancer diagnosis is ‘national disgrace’
December 10, 2013Sales and Marketing CCGs, Cancer, NHS, appgc
Cancer care is still dangerously dependent on where patients in England live according to an influential group of MPs and …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
